PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 63 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 238,409 | $6,017,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 640,000 | $1,216,000 | 0.28% |
| BAXTER BROS INC | 148,006 | $281,000 | 0.13% |
| First Heartland Consultants, Inc. | 86,204 | $164,000 | 0.08% |
| Investors Capital Advisory Services | 64,788 | $123,000 | 0.03% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 671,900 | $1,277,000 | 0.03% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $38,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 11,300 | $21,000 | 0.01% |
| FIDGEON TIMOTHY F | 14,000 | $27,000 | 0.01% |
| Commonwealth Equity Services, Inc | 505,386 | $960,000 | 0.01% |